NABL Accredited
Maternal screen (Quadruple Marker) - 2nd Trimester (14 to 22.6 weeks), Serum
Sample Collection & Prep:
3 ml of Serum.HCG-beta, AFP, uE3, Inhibin A.
Specimen Type:
Blood (Serum)
Testing Methodology:
Chemiluminescence Immunoassay (CLIA) 2 ml
Testing Schedule:
Mon–Sat Next day : 5:00pm
Report Delivery:
Within Next Day via WhatsApp & Email
Fasting Requirement:
No strict fasting required before sample collection
Quality Standard:
100% NABL Accredited clinical reference laboratory testing
Clinical Instructions:
Recommanded for 14 to 22.6 weeks with completely filled maternal TRF with barcode and latest USG report.History is mandatory.
₹3500
Test Information
Preparation requirements and diagnostic clinical parameters.
Parameters
1 Parameter- 1 diagnostic parameter
- Automated calibrated clinical analyzer
Fasting & Prep
No Fasting- No strict fasting required
- Plain drinking water intake permitted
Specimen
Blood (Serum)- Matrix: Blood (Serum)
- Prep: 3 ml of Serum.HCG-beta, AFP, uE3, Inhibin A.
Turnaround
Next Day- Report in Mon–Sat Next day : 5:00pm
- Verified PDF via WhatsApp & Email
Maternal screen (Quadruple Marker) - 2nd Trimester (14 to 22.6 weeks), Serum
1 parameter across 1 body system
General Pathology & Clinical Biochemistry Profile
Clinical laboratory investigation processed on automated diagnostic analyzers.
1 Parameter
Maternal screen (Quadruple Marker) - 2nd Trimester (14 to 22.6 weeks), Serum
Maternal screen (Quadruple Marker) - 2nd Trimester (14 to 22.6 weeks), Serum
